Skip to main content

Search Results

out of 4 results
The DAWN Report: Emergency Department Visits Involving Attention Deficit/Hyperactivity Disorder Stimulant Medications 
DAWN | Drug Abuse Warning Network
Collected Date: 2005-2010
Report Type: Short Report

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.

Emergency Department Visits for Drug-Related Suicide Attempts Involving Antidepressants More Likely to Result in Follow-up Care among Adolescents
DAWN | Drug Abuse Warning Network
Collected Date: 2008-2010
Report Type: Spotlight

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits by status of follow-up care for drug-related suicide attempts involving antidepressants among adolescents aged 12 to 17 from 2008 to 2010.

A Day in the Life of American Adolescents: Substance Use Facts Update
TEDS | Treatment Episode Data Set, DAWN | Drug Abuse Warning Network, NSDUH | National Survey on Drug Use and Health, N-SSATS | National Survey of Substance Abuse Treatment Services
Collected Date: 2010-2011
Report Type: Short Report

This short report uses data from the 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs), the 2010 Treatment Episode Data Set (TEDS), the 2010 National Survey of Substance Abuse Treatment Services (N-SSATS), and the 2011 Drug Abuse Warning Network (DAWN) to present facts about adolescent substance use...

Emergency Department Visits among Children: Psychotherapeutic Drugs Involved in Adverse Reactions or Taken by Accident
DAWN | Drug Abuse Warning Network
Collected Date: 2005-2011
Report Type: Spotlight

This Drug Abuse Warning Network (DAWN) short report discusses emergency department visits by children who consumed psychothapeutic drugs. It looks at the reasons for the visits (adverse reactions and accidental ingestion) for ages 0-5 and 6-11.